8-K: Alset Inc. Acquires DSS Note and Warrants

Alset Inc. has entered into a securities purchase agreement to acquire a convertible promissory note and warrants from DSS Inc., a company in which Alset holds a significant equity interest.

Summary

• Alset Inc. (the Company) has entered into a Securities Purchase Agreement (SPA) with DSS Inc. (DSS) on September 15, 2026.
• The Company purchased a convertible promissory note (the Note) and warrants to purchase 8,000,000 shares of DSS common stock (the Warrants) for $500,000.
• The Note accrues 3% simple interest annually and is payable on demand.
• The Company can convert the Note into DSS common stock at $0.50 per share, with conversion possible five years from the date of issuance.
• The Warrants allow the purchase of DSS common stock at $0.55 per share and expire five years from issuance.
• Both the Note conversion and Warrant exercise require approval from DSS stockholders.
• Alset Inc. holds approximately 39.4% equity in DSS, and key management personnel of Alset also hold significant positions in DSS, indicating a related party transaction.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative development due to the related party nature of the transaction and the lack of immediate clear strategic benefit, despite the potential for future upside.

Positives

• Potential to increase equity stake in DSS through conversion of the note at a favorable price ($0.50 per share) compared to the warrant exercise price ($0.55 per share).
• Acquisition of warrants provides an opportunity for future capital appreciation if DSS stock performs well.
• The transaction was approved by Alset's Board of Directors and Audit Committee.

Negatives

• The transaction involves related parties, as Alset Inc. holds a significant equity stake in DSS, and key executives/directors are common to both companies.
• The Note is payable on demand, introducing potential liquidity risk for Alset if DSS requires repayment.
• Conversion and exercise of the Note and Warrants are subject to DSS stockholder approval, creating uncertainty.
• The purchase price of $500,000 represents a significant investment for a note and warrants in a related entity.

Risks

• Dependence on DSS stockholder approval for conversion of the note and exercise of warrants.
• Potential for conflicts of interest due to common management and significant inter-company ownership.
• The value of the Note and Warrants is contingent on the future performance of DSS common stock.
• Risk that DSS may demand repayment of the convertible promissory note.
• The simple interest rate of 3% on the Note may not adequately compensate for the risk undertaken.

Future Outlook

The future outlook for this transaction is contingent on DSS stockholder approval for conversion and exercise, and the subsequent performance of DSS common stock. The Note has a five-year maturity for conversion.

Management Comments

• Chan Heng Fai and Chan Tung Moe, members of the Company's Board of Directors, recused themselves from all deliberation and voting regarding the Transaction Documents due to potential conflicts of interest.

Industry Context

StockSavvy.ai notes that transactions involving convertible notes and warrants are common in the venture capital and private equity space, often used to provide financing with equity upside potential. However, the related-party nature of this deal warrants close scrutiny regarding valuation and fairness to all shareholders.

Comparison to Industry Standards

• The terms of the convertible note (3% interest, 5-year conversion period) are within typical ranges for such instruments, though the specific valuation of DSS is not provided for direct comparison.
• The warrant exercise price of $0.55 is slightly higher than the conversion price of $0.50, which is standard practice to incentivize conversion over warrant exercise.
• The requirement for DSS stockholder approval for conversion and exercise is a common protective measure, especially in transactions involving significant equity stakes or related parties.

Corporate Governance

Related Party Transactions

• Alset Inc. purchased a convertible promissory note and warrants from DSS Inc.
• Alset Inc. holds approximately 39.4% equity interest in DSS Inc.
• Chan Heng Fai, Chairman and CEO of Alset Inc., is also the Chairman of DSS Inc.
• Chan Tung Moe, Director and Co-CEO of Alset Inc., is also a director of DSS Inc.
• Lim Sheng Hon Danny, Director and Officer of Alset Inc., is also a director of DSS Inc.
• Three independent directors of Alset Inc. (Joanne Wong Hiu Pan, Wong Shui Yeung, and William Wu) are also directors of DSS Inc.

Stakeholder Impact

• Shareholders of Alset Inc.: May benefit from potential future appreciation of DSS stock if the Note or Warrants are exercised profitably, but also face risk from the $500,000 investment and potential conflicts of interest.
• Shareholders of DSS Inc.: Their voting rights are critical for the conversion and exercise of Alset's instruments; potential dilution if conversion occurs.
• Creditors of Alset Inc.: The $500,000 investment may impact liquidity, and the Note's demand feature could pose a short-term risk.

Next Steps

• Obtain approval from DSS stockholders for the conversion of the Note and exercise of the Warrants.
• Monitor the performance of DSS Inc. to assess the value of the Note and Warrants.
• Potential conversion of the Note into DSS common stock at $0.50 per share within five years.
• Potential exercise of Warrants to purchase DSS common stock at $0.55 per share within five years.

Key Dates

Recommendation

The transaction involves a related party and requires external approval, introducing significant uncertainty. While there is potential upside if DSS performs well, the current information does not provide a clear strategic advantage or immediate financial benefit to justify a buy recommendation. The risks associated with related-party dealings and contingent approvals warrant a hold.

Keywords

Securities Purchase Agreement, Convertible Promissory Note, Warrants, Related Party Transaction, DSS Inc., Alset Inc., Stockholder Approval, Investment